A Multinational Phase IV Study Evaluating "Real World" Treatment Pattern in Previously Treated Hemophilia A Patients Receiving KOVALTRY (Octocog Alfa) for Routine Prophylaxis
Phase of Trial: Phase IV
Latest Information Update: 04 Aug 2017
At a glance
- Drugs Octocog alfa (Primary)
- Indications Haemophilia A
- Focus Therapeutic Use
- Acronyms TAURUS
- Sponsors Bayer
- 30 Jun 2017 Planned primary completion date changed from 15 Jul 2019 to 31 Jul 2019.
- 29 May 2017 Planned End Date changed from 3 Sep 2019 to 31 Dec 2019.
- 28 Nov 2016 Status changed from not yet recruiting to recruiting.